BioMed Realty Trust, Inc. (BMR) Tops Q2 FFO by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $1.46 -2.67%
Financial Fact:
Total revenues: 174.35M
Today's EPS Names:
SICP, MNSB, CFFI, More
Financial Fact:
Total revenues: 174.35M
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.32, $0.03 better than the analyst estimate of $0.29. Revenue for the quarter came in at $124.8 million versus the consensus estimate of $118.98 million.
BioMed Realty Trust, Inc. sees FY2012 FFO of $1.20-$1.28, versus the consensus of $1.24.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.
BioMed Realty Trust, Inc. sees FY2012 FFO of $1.20-$1.28, versus the consensus of $1.24.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Visteon (VC) Misses Q3 EPS by 214c
- eBay to cut 9% of workforce, expects Q3 results above guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
